Clinical features and outcomes of Chinese patients with anti‑γ‑aminobutyric acid B receptor encephalitis

Zhao,Xiu‑He; Yang,Xue; Liu,Xue‑Wu; Wang,Sheng‑Jun

doi:10.3892/etm.2020.8684

Clinical features and outcomes of Chinese patients with anti‑γ‑aminobutyric acid B receptor encephalitis

Authors:
- Xiu‑He Zhao
- Xue Yang
- Xue‑Wu Liu
- Sheng‑Jun Wang
View Affiliations

Affiliations: Department of Neurology, Qilu Hospital, Shandong University, Jinan, Shandong 250012, P.R. China
Published online on: April 23, 2020 https://doi.org/10.3892/etm.2020.8684
Pages: 617-622

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Antibodies against γ-aminobutyric acid B (GABAB) receptor are associated with limbic encephalitis (LE). It is estimated that ~1/2 of patients with LE have small‑cell lung cancer. The present study analyzed the specific GABAB receptor antibodies in serum and cerebrospinal fluid (CSF) samples of 12 patients. The clinical manifestations, therapy and outcome were retrospectively compared. The median onset age was 65.1 years and all patients presented with new‑onset seizures. In total, 11 (91.6%) patients had memory deficits, 7 (58.3%) patients had psychiatric problems and 4 (33.3%) patients had a disturbance of consciousness. Furthermore, lung cancer was detected in 7 patients (58.3%) by CT scan. Lymphocytic pleocytosis and protein concentration elevation in CSF were detected in 3 (25%) and 4 (33.3%) patients, respectively. Furthermore, MRI scan results identified 4 (33.3%) patients with abnormalities in the mesial temporal region. The lung cancer tissues of 3 patients were positively stained for anti‑GABAB receptor on immunohistochemistry. All patients received antiepileptic drugs and immunotherapy. In total, 3 patients with lung cancer were subjected to tumor resection. Those patients without cancer exhibited neurological improvement at the follow‑up. The present results suggested that seizures and memory deficits were the major manifestations in Chinese patients with anti‑GABAB receptor antibodies who were responsive to immunotherapy. The lung cancer tissues from patients with anti‑GABAB receptor antibodies were positively stained for anti‑GABAB receptor. Collectively, the present results suggested that patients with underlying lung cancer have a relatively poor prognosis.

View Figures

View References

1	Lancaster E and Dalmau J: Neuronal autoantigens--pathogenesis, associated disorders and antibody testing. Nat Rev Neurol. 8:380–390. 2012.PubMed/NCBI View Article : Google Scholar
2	Melzer N, Meuth SG and Wiendl H: Paraneoplastic and nonparaneoplastic autoimmunity to neurons in the central nervous system. J Neurol. 260:1215–1233. 2013.PubMed/NCBI View Article : Google Scholar
3	Dalmau J, Geis C and Graus F: Autoantibodies to synaptic receptors and neuronal cell surface proteins in autoimmune diseases of the central nervous system. Physiol Rev. 97:839–887. 2017.PubMed/NCBI View Article : Google Scholar
4	Lancaster E, Lai M, Peng X, Hughes E, Constantinescu R, Raizer J, Friedman D, Skeen MB, Grisold W, Kimura A, et al: Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: Case series and characterisation of the antigen. Lancet Neurol. 9:67–76. 2010.PubMed/NCBI View Article : Google Scholar
5	Höftberger R, Titulaer MJ, Sabater L, Dome B, Rózsás A, Hegedus B, Hoda MA, Laszlo V, Ankersmit HJ, Harms L, et al: Encephalitis and GABAB receptor antibodies: Novel findings in a new case series of 20 patients. Neurology. 81:1500–1506. 2013.PubMed/NCBI View Article : Google Scholar
6	Dogan Onugoren M, Deuretzbacher D, Haensch CA, Hagedorn HJ, Halve S, Isenmann S, Kramme C, Lohner H, Melzer N, Monotti R, et al: Limbic encephalitis due to GABAB and AMPA receptor antibodies: A case series. J Neurol Neurosurg Psychiatry. 86:965–972. 2015.PubMed/NCBI View Article : Google Scholar
7	Kim TJ, Lee ST, Shin JW, Moon J, Lim JA, Byun JI, Shin YW, Lee KJ, Jung KH, Kim YS, et al: Clinical manifestations and outcomes of the treatment of patients with GABAB encephalitis. J Neuroimmunol. 270:45–50. 2014.PubMed/NCBI View Article : Google Scholar
8	Guan HZ, Ren HT, Yang XZ, Lu Q, Peng B, Zhu YC, Shao XQ, Hu YQ, Zhou D and Cui LY: Limbic encephalitis associated with Anti-γ-aminobutyric Acid B receptor antibodies: A case series from china. Chin Med J (Engl). 128:3023–3028. 2015.PubMed/NCBI View Article : Google Scholar
9	Qiao S, Zhang YX, Zhang BJ, Lu RY, Lai QL, Chen LH and Wu J: Clinical, imaging, and follow-up observations of patients with anti-GABA_B receptor encephalitis. Int J Neurosci. 127:379–385. 2017.PubMed/NCBI View Article : Google Scholar
10	Zuliani L, Graus F, Giometto B, Bien C and Vincent A: Central nervous system neuronal surface antibody associated syndromes: Review and guidelines for recognition. J Neurol Neurosurg Psychiatry. 83:638–645. 2012.PubMed/NCBI View Article : Google Scholar
11	Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, Cortese I, Dale RC, Gelfand JM, Geschwind M, et al: A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 15:391–404. 2016.PubMed/NCBI View Article : Google Scholar
12	van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ and van Gijn J: Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 19:604–607. 1988.PubMed/NCBI View Article : Google Scholar
13	Hainsworth JB, Shishido A, Theeler BJ, Carroll CG and Fasano RE: Treatment responsive GABA(B)-receptor limbic encephalitis presenting as new-onset super refractory status epilepticus (NORSE) in a deployed U.S. soldier. Epileptic Disord. 16:486–493. 2014.PubMed/NCBI View Article : Google Scholar
14	Emson PC: GABA(B) receptors: Structure and function. Prog Brain Res. 160:43–57. 2007.PubMed/NCBI View Article : Google Scholar
15	Prosser HM, Gill CH, Hirst WD, Grau E, Robbins M, Calver A, Soffin EM, Farmer CE, Lanneau C, Gray J, et al: Epileptogenesis and enhanced prepulse inhibition in GABA(B1)-deficient mice. Mol Cell Neurosci. 17:1059–1070. 2001.PubMed/NCBI View Article : Google Scholar
16	Boronat A, Sabater L, Saiz A, Dalmau J and Graus F: GABA(B) receptor antibodies in limbic encephalitis and anti-GAD associated neurologic disorders. Neurology. 76:795–800. 2011.PubMed/NCBI View Article : Google Scholar
17	Jia XT, Pan Y, Di Z, Gu N, Liu Z and Kang YM: Anti-GABAB receptor encephalitis in a patient with gastric adenocarcinoma. Neurol Sci. 39:1981–1984. 2018.PubMed/NCBI View Article : Google Scholar
18	Mizuta K, Osawa Y, Mizuta F, Xu D and Emala CW: Functional expression of GABAB receptors in airway epithelium. Am J Respir Cell Mol Biol. 39:1981–1984. 2018.
19	DeLuca I, Blachère NE, Santomasso B and Darnell RB: Tolerance to the neuron-specific paraneoplastic HuD antigen. PLoS One. 4(e5739)2009.PubMed/NCBI View Article : Google Scholar
20	Titulaer MJ, Soffietti R, Dalmau J, Gilhus NE, Giometto B, Graus F, Grisold W, Honnorat J, Sillevis Smitt PA, Tanasescu R, et al: Screening for tumours in paraneoplastic syndromes: Report of an EFNS task force. Eur J Neurol. 18:e19–e3. 2011.PubMed/NCBI View Article : Google Scholar
21	Dubey D, Samudra N, Gupta P, Agostini M, Ding K, Van Ness PC, Vernino S and Hays R: Retrospective case series of the clinical features, management and outcomes of patients with autoimmune epilepsy. Seizure. 29:143–147. 2015.PubMed/NCBI View Article : Google Scholar